H Nishiguchi

Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration

Yuka Aoishi, Shoji Oura, H Nishiguchi et al. · Breast Cancer · 2020 · 41 citations

Breast Oncology, Medicine, Pathology +4

A Theoretical Model for the Hormetic Dose-response Curve for Anticancer Agents.

Tatsuya Yoshimasu, Takuya Ohashi, Shoji Oura et al. · PubMed · 2015 · 20 citations

Hormetic Reactions, Pathology, Theoretical Model +16

Epidermal Growth Factor Receptor Mutations Are Associated with Docetaxel Sensitivity in Lung Cancer

Tatsuya Yoshimasu, Shoji Oura, Fuminori Ohta et al. · Journal of Thoracic Oncology · 2011 · 16 citations · Full text

Docetaxel Sensitivity, Oncogenic Agent, Medicine +7

Class III Beta-tubulin Expression in Non-small Cell Lung Cancer: A Predictive Factor for Paclitaxel Response.

Takuya Ohashi, Tatsuya Yoshimasu, Shoji Oura et al. · PubMed · 2015 · 14 citations

A Case of Diffuse Large B Cell Lymphoma of the Breast with Predominantly High-Level Internal Echoes

M. Tomita, Shoji Oura, H Nishiguchi et al. · Case Reports in Oncology · 2020 · 13 citations · Full text

Lymphoid Neoplasia, Medical Ultrasound, Large Mass +12